Dr. Daniele Gilkes is assistant professor of oncology, as well as an assistant professor in chemical and molecular engineering at the Johns Hopkins University School of Medicine.
This is her first year as a BCRF grantee. Dr. Paul Macklin is an associate professor of intelligent systems engineering, and a member of the Melvin & Bren Simon Cancer Center at Indiana University.
He’s a BCRF grantee since 2014. Together, Drs. Gilkes and Macklin are part of a collaboration between the BCRF and JKTG Foundation that links computational scientists with biologists.
They recently talked to BCRF about their efforts to gain new insights into tumor growth, metastasis, and the mechanics of drug resistance.
Featured news
JKTG Foundation President and Founder, Ted Giovanis, Gives $35M to Study the Most Common Cause of Cancer Death: Metastasis
The Foundation is excited to announce today the creation of the Giovanis Institute for Translational Cell Biology, with a $35 million gift from researcher, philanthropist and race car driver Ted Giovanis.
Ted’s Take: Offense or Defense? When Regulations Become Two-Way Players
Legislation sets out the law, but it is in fact the regulatory agencies that interpret that law through regulations.
Ted’s Take: Priorities Should Inform Policy Decisions and Politics
Setting priorities is important. It helps get things accomplished particularly when there are multiple tasks to do. It gives order to those tasks we want to accomplish.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133